Ronald Godiska
Russian Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ronald Godiska.
Nucleic Acids Research | 2010
Ronald Godiska; David Mead; Vinay Dhodda; Chengcang Wu; Rebecca Hochstein; Attila Karsi; Karen Usdin; Ali Entezam; Nikolai V. Ravin
Despite recent advances in sequencing, complete finishing of large genomes and analysis of novel proteins they encode typically require cloning of specific regions. However, many of these fragments are extremely difficult to clone in current vectors. Superhelical stress in circular plasmids can generate secondary structures that are substrates for deletion, particularly in regions that contain numerous tandem or inverted repeats. Common vectors also induce transcription and translation of inserted fragments, which can select against recombinant clones containing open reading frames or repetitive DNA. Conversely, transcription from cloned promoters can interfere with plasmid stability. We have therefore developed a novel Escherichia coli cloning vector (termed ‘pJAZZ’ vector) that is maintained as a linear plasmid. Further, it contains transcriptional terminators on both sides of the cloning site to minimize transcriptional interference between vector and insert. We show that this vector stably maintains a variety of inserts that were unclonable in conventional plasmids. These targets include short nucleotide repeats, such as those of the expanded Fragile X locus, and large AT—rich inserts, such as 20-kb segments of genomic DNA from Pneumocystis, Plasmodium, Oxytricha or Tetrahymena. The pJAZZ vector shows decreased size bias in cloning, allowing more uniform representation of larger fragments in libraries.
Trends in Microbiology | 2010
Thomas Schoenfeld; Mark R. Liles; K. Eric Wommack; Shawn W. Polson; Ronald Godiska; David A. Mead
The enzymes of bacteriophages and other viruses have been essential research tools since the first days of molecular biology. However, the current repertoire of viral enzymes only hints at their overall potential. The most commonly used enzymes are derived from a surprisingly small number of cultivated viruses, which is remarkable considering the extreme abundance and diversity of viruses revealed over the past decade by metagenomic analysis. To access the treasure trove of enzymes hidden in the global virosphere and develop them for research, therapeutic and diagnostic uses, improvements are needed in our ability to rapidly and efficiently discover, express and characterize viral genes to produce useful proteins. In this paper, we discuss improvements to sampling and cloning methods, functional and genomics-based screens, and expression systems, which should accelerate discovery of new enzymes and other viral proteins for use in research and medicine.
PLOS ONE | 2010
Vinay Dhodda; Ronald Godiska; Jeffrey D. VanWye; David A. Mead; Rebecca Hochstein; Lynne Sheets; Sarah Vande Zande; Chris Niebauer; Douglas L. Crawford; Marjorie F. Oleksiak
Background ExCyto PCR cells provide a novel and cost effective means to amplify DNA transformed into competent bacterial cells. ExCyto PCR uses host E. coli with a chromosomally integrated gene encoding a thermostable DNA polymerase to accomplish robust, hot-start PCR amplification of cloned sequences without addition of exogenous enzyme. Results Because the thermostable DNA polymerase is stably integrated into the bacterial chromosome, ExCyto cells can be transformed with a single plasmid or complex library, and then the expressed thermostable DNA polymerase can be used for PCR amplification. We demonstrate that ExCyto cells can be used to amplify DNA from different templates, plasmids with different copy numbers, and master mixes left on ice for up to two hours. Further, PCR amplification with ExCyto cells is comparable to amplification using commercial DNA polymerases. The ability to transform a bacterial strain and use the endogenously expressed protein for PCR has not previously been demonstrated. Conclusions ExCyto PCR reduces pipetting and greatly increases throughput for screening EST, genomic, BAC, cDNA, or SNP libraries. This technique is also more economical than traditional PCR and thus broadly useful to scientists who utilize analysis of cloned DNAs in their research.
BioTechniques | 2008
Ronald Godiska; Nikolai V. Ravin; David A. Mead
Cloning large PCR products and other difficult DNA fragments is dramatically improved using Lucigen’s novel linear plasmid vector. The BigEasy• Linear Cloning Kit, containing the pJAZZ• linear vector, ensures unprecedented stability of inserts in Escherichia coli. The ends of the vector are free to rotate during replication, so the inserted DNA is not subject to torsional stress caused by supercoiling. Transcriptional terminators flank the cloning site, preventing transcriptional interference between the vector and insert.
Gene | 2011
Kavita S. Kakirde; Jadwiga Wild; Ronald Godiska; David A. Mead; Andrew G. Wiggins; Robert M. Goodman; Waclaw Szybalski; Mark R. Liles
Archive | 2001
David Mead; Ronald Godiska
Nature Methods | 2012
Chengcang Wu; Rosa Ye; Svetlana Jasinovica; Megan Wagner; Ronald Godiska; Amy Hin Yan Tong; Si Lok; Amanda Krerowicz; Curtis Knox; David A. Mead; Michael Lodes
Archive | 2007
Ronald Godiska; David Mead; Nikolai V. Ravin
The Journal of Infectious Diseases | 2016
Jason W. Benzine; Kerry M. Brown; Krystle N. Agans; Ronald Godiska; Chad E. Mire; Krishne Gowda; Brandon Converse; Thomas W. Geisbert; David A. Mead; Yogesh Chander
Archive | 2010
Eric Steinmetz; Ronald Godiska; David Mead